Vancomycin-resistant Staphylococcus aureus primary prevention

Vancomycin-resistant Staphylococcus aureus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Vancomycin-resistant Staphylococcus aureus primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Vancomycin-resistant Staphylococcus aureus primary prevention
CDC on Vancomycin-resistant Staphylococcus aureus primary prevention
Vancomycin-resistant Staphylococcus aureus primary prevention in the news
Blogs on Vancomycin-resistant Staphylococcus aureus primary prevention
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Use of appropriate infection control practices (such as wearing gloves before and after contact with infectious body substances and adherence to hand hygiene) by healthcare personnel can reduce the spread of VISA and VRSA.